CASE Op-Ed – Washington Times: Hospital Pre-payment is the Wrong Response to Beating Covid-19
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
Gerard Scimeca – Chairman, CASE April 5, 2019 – https://bit.ly/2IfnhvI In the ongoing public debate on the best way to effectuate...
This week, we submitted comments to Health and Human Services (HHS) Secretary Alex Azar, urging him to reevaluate and abandon...
MATTHEW KANDRACH President, CASE February 12, 2018 – http://bit.ly/2o1kiuZ While health care has largely been eclipsed in national media, significant...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/